BREAST CANCER NO FURTHER A MYSTERY

Focused protein degradation is remaining explored as a substitute system in cancer, whereby the organic protein degradation process is co-opted for therapeutic purposes. Not too long ago created novel molecules called proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One ligand binds t